It had already been disclosed to market in the exact same quarterly that staff costs had been reduced (Executive team focused on FY24 budget and streamlining operations to deliver YoY annual cost savings and growth) we just havent seen those figures yet.
Look, you can mock me all you want, but the reality is that your advice is transparently structured around a singular objective - getting the books in the green at the expense of business strategy and existing shareholders.
In my opinion, if they dont include an RI of some description i would imagine that the shareprice will continue to fall. A well executed RI will draw upward pressure and also offer existing shareholders an opportunity to enjoy some of the relief being offered. Hopefully they dont get their financial advice from anyone recommending to them to go into admin and recapitalize, that would pretty much guarantee a continuation of the downward spiral that is being caused by loss of trust in the board. New capital would only be in it to get their money back out again as quickly as possible, booking the discount margin as their profit.
Your advice is one dimensional, i appreciate that as an accountant it probably ticks all of your professional boxes, but it lacks nuance. But thankyou so much for sharing it, I really do appreciate hearing it.
- Forums
- ASX - By Stock
- Ann: Corporate Presentation
It had already been disclosed to market in the exact same...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CDX (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
-0.020(14.3%) |
Mkt cap ! $35.30M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 12.0¢ | $33.07K | 254.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 71953 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 38725 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 67636 | 0.120 |
3 | 310339 | 0.110 |
3 | 178800 | 0.105 |
4 | 143333 | 0.100 |
1 | 500 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 38725 | 1 |
0.135 | 20000 | 1 |
0.145 | 7872 | 1 |
0.150 | 39999 | 1 |
0.155 | 36250 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online